STAT+: AIDS activists slam Biden R&D deal with Gilead over HIV prevention drug patents
Ed Silverman·
·1 min read
·
0 reactions
·
0 comments
·
5 views
A group of AIDS activists obtained an R&D pact at the heart of a settlement between the U.S. government and Gilead Sciences over patents for HIV prevention.
Original article
STAT · Ed Silverman
Anonymous · no account needed
Discussion
0 commentsMore from STAT
STAT+: Tau in the spotlight at Alzheimer’s conference
STAT·11
STAT+: 931 days. The drug approval scandal hiding in plain sight
STAT·24
STAT+: The crumbling employer-based health insurance system
STAT·25
STAT+: Four major biotech updates to catch up on
STAT·32
STAT+: More frequent, more intense, and longer heat waves pose health risks for Americans
STAT·32
STAT+: Pharmalittle: We’re reading about Anthropic drug development goals, Trump drug plan snags, and more
STAT·40